These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23734804)

  • 21. The Implications of "Random Chance" in Cancer Genesis: Why Stochastic Can Be a Dirty Word.
    Meisenberg BR
    JAMA Oncol; 2015 Aug; 1(5):575-6. PubMed ID: 26181509
    [No Abstract]   [Full Text] [Related]  

  • 22. Precision oncology: where next?
    Gore M; Larkin J
    Lancet Oncol; 2015 Dec; 16(16):1593-5. PubMed ID: 26678189
    [No Abstract]   [Full Text] [Related]  

  • 23. Circular RNAs in cancer: opportunities and challenges in the field.
    Kristensen LS; Hansen TB; Venø MT; Kjems J
    Oncogene; 2018 Feb; 37(5):555-565. PubMed ID: 28991235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brave-ish New World--What's Needed to Make Precision Oncology a Practical Reality.
    MacConaill LE; Lindeman NI; Rollins BJ
    JAMA Oncol; 2015 Oct; 1(7):879-80. PubMed ID: 26181886
    [No Abstract]   [Full Text] [Related]  

  • 25. Circulating microRNAs: potential biomarkers for common malignancies.
    Khoury S; Tran N
    Biomark Med; 2015; 9(2):131-51. PubMed ID: 25689901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [What biomarkers for the future? The point of view of the residents in oncology after the ESMO 2016 Congress].
    Auvray M; Benderra MA; Bretagne M; Faouzi S; Lebellec L; Majhoubi L; Saint-Ghislain M; Vignot S
    Bull Cancer; 2017 Sep; 104(9):744-751. PubMed ID: 28826736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Updates in cancer research: insights from the AACR 100th Annual Meeting.
    Cho WC
    Expert Rev Mol Diagn; 2009 Jul; 9(5):411-6. PubMed ID: 19580426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted Cancer Therapies World Congress 2010--part 2. 21-23 September 2010, Zurich, Switzerland.
    Youssoufian H
    IDrugs; 2010 Dec; 13(12):833-5. PubMed ID: 21154137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Summaries of plenary and selected symposia sessions at the XXIV World Congress of Psychiatric Genetics; Jerusalem, Israel; 30 October 2016-3 November 2016.
    Ciobanu LG; Ori AP; Pagliaroli L; Polimanti R; Spindola LM; Vincent JB; Cormack FK
    Psychiatr Genet; 2017 Apr; 27(2):41-53. PubMed ID: 28212207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood Worth Bottling: Circulating Tumor DNA as a Cancer Biomarker.
    Christie EL; Dawson SJ; Bowtell DD
    Cancer Res; 2016 Oct; 76(19):5590-5591. PubMed ID: 27698187
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacogenomics: from cell to clinic (Part 1).
    Siest G; Medeiros R; Melichar B; Stathopoulou M; Van Schaik RH; Cacabelos R; Abt PM; Monteiro C; Gurwitz D; Queiroz J; Mota-Filipe H; Ndiaye NC; Visvikis-Siest S
    Pharmacogenomics; 2014 Apr; 15(5):593-9. PubMed ID: 24798716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarkers research in Europe: focus on personalized medicine.
    Metodiev MV
    Expert Rev Mol Diagn; 2011 Sep; 11(7):689-90. PubMed ID: 21902529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of Epithelial Mesenchymal Transition and Cancer Stem Cell Markers in Circulating Tumor Cells.
    Werner S; Stenzl A; Pantel K; Todenhöfer T
    Adv Exp Med Biol; 2017; 994():205-228. PubMed ID: 28560676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The evolving potential of companion diagnostics.
    Khoury JD
    Scand J Clin Lab Invest Suppl; 2016; 245():S22-5. PubMed ID: 27433788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical relevance of molecular diagnostics in gastrointestinal (GI) cancer: European Society of Digestive Oncology (ESDO) expert discussion and recommendations from the 17th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona.
    Baraniskin A; Van Laethem JL; Wyrwicz L; Guller U; Wasan HS; Matysiak-Budnik T; Gruenberger T; Ducreux M; Carneiro F; Van Cutsem E; Seufferlein T; Schmiegel W
    Eur J Cancer; 2017 Nov; 86():305-317. PubMed ID: 29065378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Automated Microfluidic Filtration and Immunocytochemistry Detection System for Capture and Enumeration of Circulating Tumor Cells and Other Rare Cell Populations in Blood.
    Pugia M; Magbanua MJM; Park JW
    Methods Mol Biol; 2017; 1634():119-131. PubMed ID: 28819845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy.
    Farwell MD; Clark AS; Mankoff DA
    JAMA Oncol; 2015 Jul; 1(4):421-2. PubMed ID: 26181243
    [No Abstract]   [Full Text] [Related]  

  • 39. Micromarkers 2.0: an update on the role of microRNAs in cancer diagnosis and prognosis.
    Ferracin M; Negrini M
    Expert Rev Mol Diagn; 2015; 15(10):1369-81. PubMed ID: 26338209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stem cell-ness: a "magic marker" for cancer.
    Lahad JP; Mills GB; Coombes KR
    J Clin Invest; 2005 Jun; 115(6):1463-7. PubMed ID: 15931383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.